Search results
Does Soaring Novavax Stock Have Enough Fuel to Climb Higher? | The Motley Fool
The Motley Fool· 1 day agoThe market was responding to terrific news from Sanofi (NASDAQ: SNY), a global pharmaceutical giant...
Mum's guilt after 'infecting baby with whooping cough' that caused brain damage
The US Sun· 1 day agoA MUM has admitted to feeling 'immense guilt' every day after passing whooping cough onto her...
Bull Market and Beyond: 2 Stocks Just Waiting to Soar
Motley Fool via Yahoo Finance· 2 days agoModerna Moderna is one of the captains of a sinking ship. As a leader in the COVID-19 vaccine...
UF Health scientists make breakthrough in possible cancer treatment
The Gainesville Sun· 21 hours agoThe vaccine uses mRNA (messenger RNA) technology and lipid nanoparticles, which a news release said...
Not sure about vaccines? How messaging is framed makes a difference, new research shows
Medical Xpress· 2 days agoWhile COVID didn't leave the world a post-apocalyptic landscape, it spotlighted the divide between...
KP.2 is now the dominant COVID variant. Experts say US may see a summer increase in cases
ABC News via Yahoo News· 2 days agoFor the last few months, JN.1 has been the dominant COVID-19 variant in the United States, making up...
Want $1,000 in Dividend Income? Here's How Much You'd Have to Invest in Pfizer Stock
The Motley Fool via AOL· 2 days agoIf you wanted to earn $1,000 in monthly income, you'd need to invest roughly $200,000. Don't have that much to invest? Don't worry. By starting with a smaller amount...achieving ...
Map shows whooping cough hotspots as 'worst outbreak in 40 years' kills 5 babies
The US Sun· 6 hours agoA MAP reveals whooping cough hotspots across England and Wales - after reports that five babies died...
Being vaccinated against COVID-19 reduces the severity of the illness
Digital Journal· 6 days agoA new study reveals how COVID-19 vaccines prevent severe disease. This is based on research...
Earnings call: Vaxart posts progress in vaccine trials, Q1 financials By Investing.com
Investing.com· 2 days agoVaxart, Inc. (NASDAQ: NASDAQ:VXRT), a biotechnology company specializing in the development of oral...